Andrew Bowen joins IBioIC from Oxford University Innovation, where he was a senior licensing and ventures manager, focusing on commercialising a variety of high-impact chemistry and life sciences projects. Additionally, he led the formation of spin-outs from Oxford University, helping them develop their business plan, build teams and secure seed funding.

Andrew Bowen, senior business engagement manager at The Industrial Biotechnology Innovation Centre (IBioIC)

Since 2016, Andrew has also been a board observer at Oxford University spin-out company EnzBond Limited, which aims to change the current understanding of biocatalysts.

In his new role, Andrew will lead Biotech Innovators – a new accelerator programme for SMEs, spinouts and start-ups launched earlier this month. He will also help to raise awareness of funding opportunities for companies in the IBioIC network and accelerate the commercialisation of strategic projects throughout the sector.

Andrew Bowen said: “I’m excited to join IBioIC and apply my experience across its range of projects. The innovation centre’s network includes so many fantastic companies using cutting-edge techniques and processes, and I’m looking forward to connecting with them and exploring how IBioIC can support them further. Biotechnology presents a great opportunity to embrace the net zero targets for Scotland and I’m keen to be part of the great work IBioIC does to reach these goals.”

Mark Bustard, CEO of IBioIC, added: “Andrew is an excellent addition to IBioIC. Having managed a large portfolio of projects within the chemistry and life sciences sectors in his role at Oxford, he brings a wealth of experience to the team. IBioIC’s main objective is to grow the bioeconomy in Scotland and Andrew will play a key role in connecting research teams with industry partners. We look forward to working with him as we continue to support companies in their journey towards net zero.”